http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-070158-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-08 |
| filingDate | 2009-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-070158-A1 |
| titleOfInvention | BENZAMIDA COMPOSITE PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE FOR THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT TO SELECTIVELY ANTAGONIZE KAPPA OPTIONAL RCEPTORS |
| abstract | A benzamide compound that is 3-fluoro-4- [4- [2- (3,5-dimethylphenyl) pyrrolidin-1-yl-methyl] phenoxy] benzamide, or (S) -3-fluoro-4- [4 - [2- (3,5-Dimethylphenyl) pyrrolidin-1-yl-methyl] phenoxy] benzamide, or a pharmaceutically acceptable salt thereof. Pharmaceutical composition that includes it. Use of said compound for the manufacture of a medicament useful for selectively antagonizing the kappa opioid receptors, such as for treating withdrawal and anxiety due to ethyl alcohol use disorder, and / or depression, or schizophrenia. Use of said compound together with a tricyclic norepinephrine reuptake inhibitor of the tertiary amine selected from amitriptyline, clomipramine, doxepine, imipramine and (+) - trimipamine, or a pharmaceutically acceptable salt thereof. |
| priorityDate | 2008-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.